MEM Stats & Data

• Identity and dose: MEM is rare; mislabeling is plausible. Use reagent testing or, if available, a drug-checking service before ingestion. Weigh doses with a calibrated 0.001 g (milligram) scale and avoid volumetric error. Allergy-test with 1–2 mg on a separate day to screen idiosyncratic reactions. Community and lab-note data support active oral dosing in the tens of milligrams; interindividual sensitivity varies notably. • Onset and redosing: Psychedelic amphetamines can have a slow come-up and very long plateau. Avoid redosing for at least 3 hours; premature redosing can produce an unexpectedly intense and prolonged experience. • Cardiovascular load: Phenethylamine psychedelics may increase heart rate and blood pressure and can cause peripheral vasoconstriction. Those with cardiovascular disease or uncontrolled hypertension should avoid use. Seek urgent care if chest pain, severe headache, confusion, or a temperature >39.5°C (103.1°F) develops. • Serotonergic/stimulant interactions: Do not combine with MAOIs (risk of hypertensive crisis or serotonin toxicity). Avoid mixing with tramadol or DXM (both lower seizure threshold/serotonergic), and avoid lithium or tricyclic antidepressants due to reports of life-threatening seizures when such agents are combined with serotonergic psychedelics. • Mental health: Strong psychedelics can precipitate or exacerbate anxiety, panic, psychosis, and mania in vulnerable individuals. People with a personal or family history of psychotic disorders or bipolar disorder should avoid use. • Setting and supervision: Use in a safe environment with a trusted, sober sitter; plan for 16–24 hours without responsibilities, driving, or operating machinery, plus an aftercare window for rest and nutrition. • Hydration/temperature: Maintain normal hydration and temperature; avoid strenuous activity and hot environments to reduce hyperthermia risk during stimulation. • Sleep/recovery: Expect sleep disruption the night after; schedule recovery time. • Frequency/tolerance: Cross-tolerance occurs with other psychedelics. Spacing sessions by at least 1–2 weeks (preferably longer) reduces tolerance build-up and psychological strain. • Unknown toxicology: Human pharmacokinetics and long-term safety are uncharacterized. Conservative dosing and avoidance of poly-drug use are key.